DCGI permits Bharat Biotech to conduct trials for intranasal booster dose

28-01-2022 Fri 18:37
DCGI permits Bharat Biotech to conduct trials for intranasal booster dose

New Delhi, Jan 28:  In a major development on Friday, the Drugs Controller General of India (DCGI) allowed Hyderabad-based vaccine manufacturer Bharat Biotech to conduct clinical trials for its intranasal Covid booster dose in India.

The clinical trials will be conducted at nine different sites, including AIIMS Delhi.

The vaccine manufacturer had proposed the booster dose for those who have been already been inoculated with Covishield and Covaxin vaccines.

"Granting permission to conduct clinical trials with vaccine does not convey or imply that, based on the clinical trial data generated with the vaccine, permission to market this vaccine in the country will automatically be granted," said the national drugs regulator.

Bharat Biotech plans to conduct clinical trials on both who have taken Covishield or Covaxin vaccine shots. As per sources, the trials will be conducted on half individuals who have received Covishield and another half who have been administered Covaxin.

A gap of around six months is expected between the second vaccine shot and the intranasal booster dose.

The intranasal vaccine reportedly has the potential to prevent transmission of new Covid variants. 


More English News
TS SI written test on August 7
Global Covid caseload tops 527.2 mn
City bus services available from midnight in Hyderabad
Telugu woman gets rare award in UK
IRCTC Ramayana tour offers an EMI option
Digital health system great equaliser to support Universal Health Coverage: Mandaviya
Bihar girl travels 1 km on 1 leg to reach school
Not easy to part ways after long association: Kapil Sibal on leaving Cong
Biennial elections for 30 Legislative Council seats on June 20
Visa scam case: Karti Chidambaram to appear before CBI on Thursday
IPL 2022, Eliminator: Patidar's century, Hazlewood's three wickets power Bangalore to Qualifier 2
Bypolls for 3 Parliamentary, 7 Assembly constituencies on June 23
IPL 2022: Rajat Patidar's 49-ball century powers Bangalore to 207/4 against Lucknow
Assam flood: Toll rises to 28; over 5 lakh affected
Nehru's statue damaged in MP, Congress demands probe